The World Health Organization’s (WHO) first line recommendation for the prevention of PPH is the administration of oxytocin 10 IU [7], an injectable uterotonic which requires refrigeration during transportation and storage to remain effective [8]. This evidence concerns the gene OXT and pulmonary arterial hypertension.